Evommune Stock

www.evommune.com/HealthcareFounded: 2020

Evommune, founded in 2020, is a biotechnology company that focuses on developing treatments for highly prevalent inflammatory diseases. Taking a tissue-based approach to insights and accelerating the development of transformative medicines for inflammatory diseases, Evommune seeks to create strategies to treat inflammatory disorders by developing treatments that address symptoms while also halting disease progression. Evommune is headquartered in Palo Alto, California.

Register for Details

For more details on financing and valuation for Evommune, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Evommune.

Register Today

Evommune investors also invested in these private companies

Andera Partners
Pivotal bioVenture Partners
LSP BioVentures
Amplitude Venture Capital
Arix Bioscience
EQT Life Sciences

Team

Management Team

Luis Peña
Co-Founder, Chief Executive Officer & President
Kyle Carver
Chief Financial Officer
Jeegar Patel Ph.D
Chief Scientific Officer
Hans Hofland Ph.D
Co-Founder & Senior Vice President of Research
Gregory Moss
Chief Corporate Strategy & Legal Officer
Eugene Bauer
Chief Medical Officer

Board Members

Ashish Khanna Ph.D
Pivotal bioVenture Partners
Felice Verduyn-Van Weegen
EQT Life Sciences

Other companies like Evommune in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B